Showing results (341-350 of 579) with videos related to

Sort By:
Pageof 58
Annals of Translational Medicine|April 18, 2022
Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphomaNana Ping, Changju Qu, Mengyun Li, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 15, 2021
Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia AYongqiang Zhao, Yu Hu, Jie Jin, et al.
Frontiers in Oncology|February 8, 2021
Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of LiteratureXuewei Li, Nana Ping, Yong Wang, et al.
International Journal of Hematology|February 22, 2008
B-Lymphoid and myeloid lineages biphenotypic acute leukemia with t(8;21)(q22;q22)Guangsheng He, Depei Wu, Aining Sun, et al.
Blood|August 26, 2020
Targeting the Otub1/c-Maf axis for the treatment of multiple myelomaYujia Xu, Min Xu, Jiefei Tong, et al.
Bone Marrow Transplantation|August 1, 2024
First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective studyLimin Liu, Bing Han, Yanming Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 19, 2021
Copper Promotes Tumorigenesis by Activating the PDK1-AKT Oncogenic Pathway in a Copper Transporter 1 Dependent MannerJianping Guo, Ji Cheng, Nana Zheng, et al.
Leukemia Research|May 5, 2018
Chinese and Europeans with acute myeloid leukemia have discordant mutation topographiesMin Zhang, Jiawei Yin, Qinghua He, et al.
European Journal of Immunology|December 29, 2017
IL-12/IL-18-preactivated donor NK cells enhance GVL effects and mitigate GvHD after allogeneic hematopoietic stem cell transplantationYuan Song, Bo Hu, Yonghao Liu, et al.
Bone Marrow Transplantation|August 28, 2023
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMTJia Chen, Myriam Labopin, Thomas Pabst, et al.
Pageof 58